HOME >> BIOLOGY >> NEWS
Xenical improves glycaemic control in those poorly controlled on anti-diabetic medication

SAN FRANCISCO, June 17, 2002 Treatment with the prescription weight-loss medication Xenical (orlistat) provides additional glycaemic control benefits in overweight or obese patients with type 2 diabetes taking maximal or near-maximal doses of anti-diabetic medications, according to new data presented at the American Diabetes Association (ADA) in San Francisco1. Results were consistent regardless of the type of oral anti-diabetic treatment patients were receiving.

"These results are important for patients who are struggling to control their glucose levels without resorting to daily insulin injections," said Professor Stephan Jacob, M.D, medical director of the Albert Schweitzer Klinik, Knigsfeld, Germany. "The findings suggest that weight loss with Xenical plus diet may provide physicians with another tool to control blood sugar in overweight or obese patients with type 2 diabetes, and prolong the utility of oral anti-diabetes medications."

This data should come as welcome news to physicians in their ongoing battle to control glucose levels in this difficult to treat patient group.

Study Outcomes
Researchers analysed data from seven double-blind, placebo-controlled trials of Xenical in overweight or obese patients with type 2 diabetes who were being treated with oral anti-diabetic medications. Patients were randomised to receive either Xenical 120 mg or placebo three times per day.

A sub-group of patients receiving maximal or near maximal doses of either metformin (2000 mg) or sulfonylureas (80% of standardised dose) was identified. This group was analysed to determine treatment effects on HbA1c levels and fasting plasma glucose (FPG) both measures of glycaemic control. In the metformin group, researchers found that, compared to the placebo group, Xenical had a significantly greater impact on both HbA1c (-0.81% Xenical vs. -0.38% placebo) and FPG levels (-1.74 mmol/L Xenical vs. -0.38 mmol/L placebo). In pat
'"/>

Contact: Liz Gofton
liz.gofton@shirehealthinternational.com
44-207-471-1518
Shire Health International
18-Jun-2002


Page: 1 2

Related biology news :

1. New data shows weight loss with Xenical provides benefits for type 2 diabetes patients
2. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
3. Study shows that ultrasound accreditation improves the quality of ultrasound practice
4. Small trial shows daclizumab add-on therapy improves MS outcome
5. Combination therapy dramatically improves function after spinal cord injury in rats
6. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
7. Longer-term, moderate exercise improves immune activity
8. New approach limits damage after heart attack and improves survival, say Scripps Research scientists
9. Online calculator improves analysis of chemical data
10. Dec. 17 JAMA study shows new biologic drug reduces psoriasis symptoms, improves quality of life
11. Standard improves tests of male DNA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... and PETACH TIKVAH, Israel , April 20, ... developer of adult stem cell technologies for neurodegenerative diseases, announced ... present at the Alliance for Regenerative Medicine,s (ARM) 5 th ... April 27, 2017 at 09:40 EDT in Boston ... , MD, MHSc, Chief Medical Officer & Chief Operating Officer, ...
(Date:4/19/2017)... ... April 18, 2017 , ... ... Labs . The move comes after the company changed focus to making analytical ... new brand and our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, ...
(Date:4/19/2017)... Oregon and PUNE, India , April 19, 2017 ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the ... garner $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to ... ... ...
(Date:4/18/2017)... ... April 18, 2017 , ... METTLER TOLEDO ... to concentration levels and vice-versa. , One of the key applications for the ... concentration control or monitoring. The principle of this analytical method is based on ...
Breaking Biology Technology:
Cached News: